生物结合抗瘤的合理设计,具有瘤选择性向和微环境响应激活
Chunlai Feng1,2, Wen Deng3, Min Cai3
1School of Pharmacy, Jiangsu University, 301 Xuefu Road, Zhenjiang, 212013, Jiangsu Province, China. feng@ujs.edu.cn.
Pharmaceutical research
|December 10, 2025
概括
研究人员开发了一种新型的酸合抗微生物 (PBA-AMP),用于增强癌症治疗. 这种向性在临床前模型中显示出改善的瘤选择性,提高疗效和降低毒性,为抗瘤治疗提供了一个有希望的新途径.
科学领域:
- 生物化学和分子生物学
- 药理学和毒理学 药理学和毒理学
- 在瘤学瘤学.
背景情况:
- 生物活性在癌症治疗中表现有前途,但患有瘤选择性差和全身毒性.
- 开发具有增强瘤向能力的酸对于临床应用至关重要.
研究的目的:
- 为了设计一个多功能抗瘤,提高瘤选择性和治疗疗效.
- 创建一种与酸结合的抗微生物 (PBA-AMP) 用于向癌症治疗.
主要方法:
- 用4 - 乙烯基酸化学修饰一个阴离子抗微生物 (AMP).
- 分子动力学模拟以评估膜相互作用.
- 在体外细胞吸收和细胞毒性测定 (MCF-7细胞).
- 在体内瘤向,抗瘤疗效和毒性研究 (4T1瘤携带小鼠).
主要成果:
- 在模拟中,PBA-AMP证明了与瘤细胞膜的快速,稳定的结合.
- 与原生AMP (IC50 = 110 μM) 相比,增强了PBA-AMP对MCF-7细胞的细胞吸收和细胞毒性 (IC50 = 38.46 μM).
- 在体内研究表明,选择性,长时间的瘤积累和显著的瘤生长抑制没有可观察到的全身毒性.
结论:
- 提出了针对瘤选择性,微环境响应性治疗的合理设计策略.
- PBA-AMP是向癌症治疗的有希望的候选者,其疗效提高,非向效应减少.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K


